Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Oct;29(4):257-9.
doi: 10.4103/0972-3919.142635.

Pancreatic tuberculosis: Evaluation of therapeutic response using F-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography

Sampath Santhosh  1 , Anish Bhattacharya  1 , Surinder Singh Rana  2 , Deepak Kumar Bhasin  2 , Radhika Srinivasan  3 , Bhagwant Rai Mittal  1
Affiliations
Case Reports

Pancreatic tuberculosis: Evaluation of therapeutic response using F-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography

Sampath Santhosh et al. Indian J Nucl Med. 2014 Oct.

Abstract

F-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG PET/CT) is a functional imaging technique that monitors glucose metabolism in tissues. Pulmonary tuberculosis (TB) has been reported to show intense uptake of FDG, with a decrease in metabolism of the tuberculous lesions after successful anti-tubercular treatment (ATT). The authors present a patient with pancreatic TB and demonstrate the usefulness of FDG PET/CT in monitoring the response to ATT.

Keywords: F-18 fluoro-2-deoxy-D-glucose; pancreas; positron emission tomography/computed tomography; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Maximum intensity projection (a), axial computed tomography (CT) (b) and axial fused positron emission tomography/CT (c) images of the baseline scan showing increased F-18 fluoro-2-deoxy-D-glucose uptake (standardized uptake value 23.4) in the peripancreatic lesion (arrowhead) as well as in enlarged supraclavicular, mediastinal and retro-peritoneal lymph nodes and the marrow of the humeri (arrows)
Figure 2
Figure 2
Maximum intensity projection (a), axial computed tomography (CT) (b) and axial fused positron emission tomography/CT (c) images 3 months after starting anti-tubercular treatment, showing complete resolution of the lesions in the pancreatic head and elsewhere. The peripancreatic lymph nodes (b and c) show a significant reduction in size and F-18 fluoro-2-deoxy-D-glucose avidity (standardized uptake value 4.7)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Tan KK, Chen K, Liau KH, Ho CK. Pancreatic tuberculosis mimicking pancreatic carcinoma: Series of three cases. Eur J Gastroenterol Hepatol. 2009;21:1317–9. - PubMed
    1. Xia F, Poon RT, Wang SG, Bie P, Huang XQ, Dong JH. Tuberculosis of pancreas and peripancreatic lymph nodes in immunocompetent patients: Experience from China. World J Gastroenterol. 2003;9:1361–4. - PMC - PubMed
    1. Pandya G, Dixit R, Shelat V, Dixit K, Shah N, Shah K. Obstructive jaundice: A manifestation of pancreatic tuberculosis. J Indian Med Assoc. 2007;105:133–4,136. - PubMed
    1. Pombo F, Díaz Candamio MJ, Rodriguez E, Pombo S. Pancreatic tuberculosis: CT findings. Abdom Imaging. 1998;23:394–7. - PubMed
    1. Song TJ, Lee SS, Park do H, Lee TY, Lee SO, Seo DW, et al. Yield of EUS-guided FNA on the diagnosis of pancreatic/peripancreatic tuberculosis. Gastrointest Endosc. 2009;69:484–91. - PubMed

Publication types